Tuhin Virmani is a Neurology physician affiliated with University of Arkansas Medical Center. OpenAlex indexes 89 publications with 1,592 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4301 W Markham St
Slot 500
Little Rock, AR 722057101
Telephone
501-526-6169Registry record last updated 3 Jul 2013.
Clinical trials
- Comparison of Health Care Delivery Methods in Parkinson's Disease
Sponsor: University of Arkansas
- Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)
Sponsor: University of Arkansas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Saluda Medical Americas, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.1%Aromatic Amino Acid Decarboxylation Inhibitor33.9%Carbidopa-Levodopa54%Rytary36%Carbidopa-Levodopa Er10%Part D≥93 patientsBenzodiazepine11.3%Clonazepam92%Diazepam9%Part D<11 patients+ 15 more classes in this area
Cardiovascular
2.4%Beta blocker1.7%Propranolol Hcl100%Part D<11 patientsalpha-Adrenergic Agonist0.7%Midodrine Hcl100%Part D<11 patientsMetabolism & gastrointestinal
1.5%Anticholinergic0.8%Atropine Sulfate100%Part D<11 patientsProton pump inhibitor0.7%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Exploring the relationship between orthostatic hypotension and gait in people with Parkinson’s disease
Clinical Autonomic Research
2025 - Feasibility of regional center telehealth visits utilizing a rural research network in people with Parkinson’s disease
Journal of Clinical and Translational Science
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Thrasher, MD
University of Arkansas Medical Center
Monique Spillman, MD
University of Arkansas Medical Center
Erika Petersen, MD
University of Arkansas Medical Center
T. Pait, MD
University of Arkansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”